Dr. Megan E. Daly
Claim this profileUniversity of California Davis Comprehensive Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
24 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage I
2Non-Small Cell Lung Cancer
Stage III
Stage IV
Stage I
Affiliated Hospitals
Clinical Trials Megan E. Daly is currently running
Targeted Radionuclide Therapy
for Non-Small Cell Lung Cancer
This is a Phase I study to evaluate the safety and efficacy of the \[68Ga\]Ga DOTA-5G and \[177Lu\]Lu DOTA-ABM-5G theranostics pair in patients with metastatic non small cell lung cancer (NSCLC).
Recruiting1 award Phase 1
TRC102 + Chemotherapy/Radiation
for Lung Cancer
This phase II trial tests whether TRC102 (methoxyamine hydrochloride) in combination usual care treatment comprised of pemetrexed, cisplatin or carboplatin, and radiation therapy followed by durvalumab works better than the usual care treatment alone to shrink tumors in patients with stage III non-squamous non-small cell lung cancer (NSCLC). TRC102 is in a class of drugs called antineoplastic agents. It blocks the ability of a cell to repair damage to its deoxyribonucleic acid (DNA) and may kill tumor cells. It may also help some anticancer drugs work better. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make DNA and may kill tumor cells. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy sources to kill tumor cells and shrink tumors. Giving TRC102 in combination with usual care treatment may be more effective than usual care treatment alone in stabilizing and lengthening survival time in patients with stage III non-squamous NSCLC.
Recruiting1 award Phase 224 criteria
More about Megan E. Daly
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Megan E. Daly has experience with
- Pembrolizumab
- Stereotactic Body Radiation Therapy
- Atezolizumab
- Carboplatin
- Cisplatin
- Durvalumab
Breakdown of trials Megan E. Daly has run
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Lung Adenocarcinoma
Oligoprogressive
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Megan E. Daly specialize in?
Megan E. Daly focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Megan E. Daly currently recruiting for clinical trials?
Yes, Megan E. Daly is currently recruiting for 6 clinical trials in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that Megan E. Daly has studied deeply?
Yes, Megan E. Daly has studied treatments such as Pembrolizumab, Stereotactic Body Radiation Therapy, Atezolizumab.
What is the best way to schedule an appointment with Megan E. Daly?
Apply for one of the trials that Megan E. Daly is conducting.
What is the office address of Megan E. Daly?
The office of Megan E. Daly is located at: University of California Davis Comprehensive Cancer Center, Sacramento, California 95817 United States. This is the address for their practice at the University of California Davis Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.